Graves ophthalmopathy

(redirected from Graves' Orbitopathy)

Graves oph·thal·mop·a·thy

(grāvz),
exophthalmos caused by increased water content of retroocular orbital tissues; associated with thyroid disease, usually hyperthyroidism.

Graves oph·thal·mop·a·thy

(grāvz ofthăl-mopă-thē)
Exophthalmos caused by increased water content of retroocular orbital tissues; associated with thyroid disease, usually hyperthyroidism.

Graves,

Robert James, Irish physician, 1796-1853.
Graves disease - thyroid dysfunction and all or any of its clinical associations. Synonym(s): Basedow disease; Marsh disease; ophthalmic hyperthyroidism; Parry disease
Graves ophthalmopathy - exophthalmos associated with thyroid disease. Synonym(s): endocrine ophthalmopathy; Graves orbitopathy
Graves orbitopathy - Synonym(s): Graves ophthalmopathy

Graves oph·thal·mop·a·thy

(grāvz ofthăl-mopă-thē)
Exophthalmos caused by increased water content of retroocular orbital tissues; associated with thyroid disease, usually hyperthyroidism.
References in periodicals archive ?
Mourits, "Effect of smoking on orbital fat and muscle volume in Graves' orbitopathy," Thyroid, vol.
GO severity was evaluated according to the European Groups on Graves' Orbitopathy (EUGOGO) recommendations [23].
Guthoff, "Functional and esthetic outcome after bony lateral wall decompression with orbital rim removal and additional fat resection in Graves' orbitopathy with regard to the configuration of the lateral canthal region," Orbit, vol.
Graves' Orbitopathy. Graves' orbitopathy is present in around 30% of patients at the time of diagnosis of GD [40, 60].
Woog, "Evaluation and management of Graves' orbitopathy," Otolaryngologic Clinics of North America, vol.
The body of clinical evidence with teprotumumab includes top-line positive results from the Phase 3 confirmatory clinical trial, called OPTIC (Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis with Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study), presented at the 2019 American Association of Clinical Endocrinologists (AACE) meeting, as well as positive Phase 2 results.
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study.
TED, also known as Graves' orbitopathy (GO), affects approximately 25% of patients with Graves' disease and is influenced by gender with females being more at risk (approximately 5:1).
After hosting a call featuring an expert focused on thyroid eye disease, also known as Graves' orbitopathy, Piper Jaffray analyst David Amsellem reiterates an Overweight rating on Horizon Pharma with a $25 price target.
Type 2 diabetic patients with Graves' disease have more frequent and severe Graves' orbitopathy. Nutr Metab Cardiovasc Dis.
Kahaly, "Graves' Orbitopathy: A Multidisciplinary Approach--Questions and Answers," Graves' Orbitopathy: A Multidisciplinary Approach--Questions and Answers, 2010.